MS News that Caught My Eye Last Week: Popular DMTs, Data Analysis Predicts MS, Remyelination Study
Oral DMTs Still Common 1st Therapy for New MS Patients but Ocrevus Having Impact, Market Report Says Deciding on what therapy to use is a tough decision for people with MS and their doctors. That’s especially true for someone who is newly diagnosed. Do you go with…